| References |
Patients (n) |
ORR (%) |
≥nCR (%) |
≥VGPR (%) |
PR (%) |
MR/SD (%) |
| Our pts. |
41 |
78 |
17 |
54 |
24 |
10 |
| Cavo et al. [11] |
236 |
93 |
31 |
62 |
31 |
7 |
| Rosinol et al. [12]* |
130 |
85 |
35 |
60 |
25 |
6 |
| Moreau et al. [13]** |
100 |
88 |
31 |
49 |
39 |
NR |
| Kaufman et al.[14]*** |
44 |
91 |
20 |
57 |
34 |
5 |
| Buda et al. [15]** |
43 |
91 |
30 |
51 |
40 |
7 |
|
| ORR: Overall Response Rate (≥PR); CR=Complete Response; nCR=Near
Complete Response; VGPR: Very Good Partial Response; PR: Partial
Response; MR: Minor Response; SD: Stable Disease; NR=Not Reported. *6
cycles VTD, **4 cycles VTD, ***median duration of VTD-induction: 4 cycles
(range 2-8 cycles). |
| Table 2b: Response rate after VTD-induction therapy compared with
the results of other VTD-trials. |
